About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
F
Current Recommendations on Managing Dermatologic Adverse Reactions Associated With Amivantamab Therapy for mNSCLC
By
Fawzi Abu Rous
0 views
May 16, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
09:36
Johnson & Johnson
Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…
Feat.
J. Heymach,
M. Das
Featured Video
06:27
Johnson & Johnson
Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC
Feat.
M. Socinski,
D. Waterhouse
Recommended
AUTOPLAY
ON
Related
Newest
35:40
Balazs Halmos
Year in Review: Lung Cancer
17:20
Total Health
2024 Intervention Selection & Sequencing in Early Stage NSCLC
Feat.
J. Porter
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
11:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…
Feat.
J. West
36:14
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …
Feat.
B. Halmos
16:10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…
Feat.
L. Raez
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…
Feat.
V. Subbiah
14:49
Vivek Subbiah
Year in Review: Precision Medicine
26:21
Memorial Sloan Kettering Cancer Center
NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…
Feat.
M. Hwang
19:33
ecancer
ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC
Feat.
E. Felip,
A. Spira,
A. Passaro,
A. Addeo
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
09:40
John Conibear
PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC
21:24
Chul Kim
ADCs and Bispecific Inhibitors in NSCLC
08:30
Insights from 2023 ESMO Annual Meeting
PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…
Feat.
N. Girard
05:02
GRACE
Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC
Feat.
A. Desai
11:45
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxe…
Feat.
T. Mok
20:27
Yale Cancer Center
Progress in the Treatment of NSCLC
Feat.
R. Herbst
18:09
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
The Changing Prognosis of Lung Cancer Brain Metastases
Feat.
S. Goldberg
23:32
2023 West Oncology Conference
2023 Updates on Neoadjuvant and Adjuvant NSCLC
Feat.
M. Johnson
